Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.
Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J.
Hepatology. 2017 Jan;65(1):310-335. doi: 10.1002/hep.28906. Epub 2016 Dec 1.
Liver cirrhosis.
Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS.
Lancet. 2021 Oct 9;398(10308):1359-1376. doi: 10.1016/S0140-6736(21)01374-X. Epub 2021 Sep 17.
Liver cirrhosis.
Tsochatzis EA, Bosch J, Burroughs AK.
Lancet. 2014 May 17;383(9930):1749-61. doi: 10.1016/S0140-6736(14)60121-5. Epub 2014 Jan 28.
Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.
Sharpton SR, Loomba R.
Hepatology. 2023 Dec 1;78(6):1896-1906. doi: 10.1097/HEP.0000000000000278. Epub 2023 Jan 3.
Clinical states of cirrhosis and competing risks.
D'Amico G, Morabito A, D'Amico M, Pasta L, Malizia G, Rebora P, Valsecchi MG.
J Hepatol. 2018 Mar;68(3):563-576. doi: 10.1016/j.jhep.2017.10.020. Epub 2017 Oct 27.
Pathophysiology of portal hypertension.
Iwakiri Y.
Clin Liver Dis. 2014 May;18(2):281-91. doi: 10.1016/j.cld.2013.12.001. Epub 2014 Feb 25.
Haemostatic alterations and management of haemostasis in patients with cirrhosis.
Lisman T, Caldwell SH, Intagliata NM.
J Hepatol. 2022 Jun;76(6):1291-1305. doi: 10.1016/j.jhep.2021.11.004.
Liver fibrosis.
Bataller R, Brenner DA.
J Clin Invest. 2005 Feb;115(2):209-18. doi: 10.1172/JCI24282.
Application of ultrasound for the diagnosis of cirrhosis/portal hypertension.
Han SK, Kim MY, Kang SH, Baik SK.
J Med Ultrason (2001). 2022 Jul;49(3):321-331. doi: 10.1007/s10396-022-01191-w. Epub 2022 Feb 18.
Predicting portal thrombosis in cirrhosis: Some issues.
Dai CY, Chuang WL, Yu ML.
J Hepatol. 2022 Jan;76(1):224-225. doi: 10.1016/j.jhep.2021.08.015. Epub 2021 Aug 27.
